Madhavan Balachandran
CIK: 0001555508
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 17, 2026QURE
uniQure N.V.
Exercise(M)Direct6.4K shares at avg. $19.39$124K - Jun 17, 2026QURE
uniQure N.V.
Sale(S)Direct1.7K shares at avg. $42.60$72K - Jun 17, 2026QURE
uniQure N.V.
Sale(S)Direct4.7K shares at avg. $43.66$205K - Jun 17, 2026QURE
uniQure N.V.
Sale(S)Direct5.3K shares at avg. $47.08$249K - Jun 17, 2026QURE
uniQure N.V.
Exercise(M)Direct5.3K shares at avg. $31.71$168K - Jun 15, 2026STVN
Stevanato Group S.p.A.
Sale(S)Direct1.5K shares at avg. $17.09$26K - Jun 15, 2026QURE
uniQure N.V.
Sale(S)Direct10K shares at avg. $27.85$279K - Jun 15, 2026QURE
uniQure N.V.
Exercise(M)Direct10K shares at avg. $8.49$85K - Jun 12, 2026STVN
Stevanato Group S.p.A.
Award(A)Direct5K shares- - Jun 11, 2026QURE
uniQure N.V.
Sale(S)Direct2K shares at avg. $27.06$54K - Jun 10, 2026QURE
uniQure N.V.
Award(A)Direct7.6K shares- - Apr 1, 2026REPL
Replimune Group, Inc.
Award(A)DirectStock Option (right to buy)
44.5K shares- - Jun 20, 2025QURE
uniQure N.V.
Sale(S)Direct2.1K shares at avg. $14.45$31K - Jun 11, 2025QURE
uniQure N.V.
Award(A)Direct8K shares- - Apr 1, 2025REPL
Replimune Group, Inc.
Award(A)DirectStock Option (right to buy)
32K shares- - Sep 4, 2024REPL
Replimune Group, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
64K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 | QURE uniQure N.V. | Exercise(M) | 6,390 | $19.39 | $123,902 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Sale(S) | 1,690 | $42.60 | $71,994 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Sale(S) | 4,700 | $43.66 | $205,202 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Sale(S) | 5,295 | $47.08 | $249,289 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Exercise(M) | 5,295 | $31.71 | $167,904 | Direct |
| Jun 15, 2026 | STVN Stevanato Group S.p.A. | Sale(S) | 1,493 | $17.09 | $25,515 | Direct |
| Jun 15, 2026 | QURE uniQure N.V. | Sale(S) | 10,000 | $27.85 | $278,500 | Direct |
| Jun 15, 2026 | QURE uniQure N.V. | Exercise(M) | 10,000 | $8.49 | $84,900 | Direct |
| Jun 12, 2026 | STVN Stevanato Group S.p.A. | Award(A) | 4,975 | - | $0 | Direct |
| Jun 11, 2026 | QURE uniQure N.V. | Sale(S) | 1,993 | $27.06 | $53,931 | Direct |
| Jun 10, 2026 | QURE uniQure N.V. | Award(A) | 7,550 | - | $0 | Direct |
| Apr 1, 2026 | REPL Replimune Group, Inc. | Award(A) Stock Option (right to buy) | 44,500 | - | - | Direct |
| Jun 20, 2025 | QURE uniQure N.V. | Sale(S) | 2,112 | $14.45 | $30,518 | Direct |
| Jun 11, 2025 | QURE uniQure N.V. | Award(A) | 7,970 | - | - | Direct |
| Apr 1, 2025 | REPL Replimune Group, Inc. | Award(A) Stock Option (right to buy) | 32,000 | - | - | Direct |
| Sep 4, 2024 | REPL Replimune Group, Inc. | Award(A) Employee Stock Option (right to buy) | 64,000 | - | - | Direct |
1-16 of 16 transactions
About Balachandran Madhavan
Balachandran Madhavan (SEC CIK 0001555508) files insider reports with the SEC as Director of Stevanato Group S.p.A. (STVN), Director of uniQure N.V. (QURE) and Director of Replimune Group, Inc. (REPL).
Signal8 holds 11 ownership filings by Balachandran Madhavan (2 Form 3, 9 Form 4), filed between Sep 5, 2024 and Jun 26, 2026. Those filings report 16 transactions, from Sep 4, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Balachandran Madhavan's filings is in AMSTERDAM.
Recent filings by Balachandran Madhavan
- Jun 17, 2026: Option exercise of QURE shares (Form 4, code M).
- Jun 17, 2026: Open-market sales of QURE shares (3 lines, Form 4, code S).
- Jun 17, 2026: Option exercise of QURE shares (Form 4, code M).
- Jun 15, 2026: Open-market sale of STVN shares (Form 4, code S).
- Jun 15, 2026: Open-market sale of QURE shares (Form 4, code S).
Other insiders filing for Stevanato Group S.p.A. (STVN)
- Santel Luciano, Director
- Dal Lago Marco, Chief Financial Officer
- Magistretti Elisabetta, Director
- LIN SUE-JEAN, Director
- MOREL DONALD E JR, Director
- Stocchi Mauro